Latest news with #RashedObaidAlsuwaidi
Al Etihad
15-05-2025
- Health
- Al Etihad
ADPHC signs strategic partnership agreement with Institute for Healthier Living Abu Dhabi to enhance community health and wellbeing
15 May 2025 23:40 ABU DHABI (ALETIHAD)The Abu Dhabi Public Health Centre (ADPHC) has signed a strategic partnership agreement with the Institute for Healthier Living Abu Dhabi (IHLAD) to further enhance the community's health and well-being through innovation, personalised care, and targeted lifestyle early interventions. The agreement was signed on the sidelines of the 25th IUHPE World Conference on Health Promotion, a global event hosted in Abu Dhabi for the first time in the Middle East, under the theme Settings for Planetary Health and and IHLAD are collaborating to improve the lives of Abu Dhabi's residents through preventing and managing lifestyle-related diseases, including diabetes, heart disease, obesity, hypertension, and other cardiometabolic to the agreement, IHLAD will utilise the health data extracted from the comprehensive health screening programme (IFHAS). The institute will enrol participants through voluntary consent. Individuals will be classified according to age, gender and clinical risk factors. Participants will receive specialised care, following an exceptional proactive therapeutic approach, through the integration of advanced diagnostic technologies and evidence-based preventive strategies to more effectively treat lifestyle-related diseases. Dr. Rashed Obaid Alsuwaidi, Director General of the Abu Dhabi Public Health Centre (ADPHC), said: 'Abu Dhabi Public Health Centre's strategic partnership with the Institute for Healthier Living Abu Dhabi (IHLAD) serves as a testament to our commitment to enhance the health and well-being of all community members. Through this collaboration, we remain dedicated to empowering our community to lead longer, healthier lives by prioritising proactive preventative approaches, early detection and integration of cutting-edge innovations in data analytics, life science and artificial intelligence (AI) across the healthcare ecosystem.'In Abu Dhabi, we leverage the Malaffi platform and the comprehensive health screening programme (IFHAS) to gather valuable insights on the population's health needs. These initiatives enable us to support community members in adopting healthy lifestyles that enhance their current and future well-being.'Dr. Nicole Sirotin, CEO of the Institute for Healthier Living Abu Dhabi, said: 'The Institute for Healthier Living Abu Dhabi is collaborating closely with Abu Dhabi Public Health Centre (ADPHC) and other UAE government entities to develop a comprehensive, forward-thinking approach to enhancing the health and longevity of the UAE's population. By harnessing advanced technology, artificial intelligence, and precision lifestyle medicine, we are transforming the healthcare system into one that proactively identifies individuals at high risk for disease and implements personalised, preventive strategies to mitigate complications before they arise.'Innovative diagnostics, such as biomarkers, AI-based retinal scans and multi-omics testing, will be introduced to advance early detection and diagnosis. Personalised nutrition and fitness plans, designed with evidence from the American College of Lifestyle Medicine and other prestigious global entities, will empower individuals to make informed health Department of Health – Abu Dhabi has recently announced the introduction of a groundbreaking licensing framework to establish Healthy Longevity Medicine Centres (HLMCs). This initiative, the first of its kind globally, enables the centres to provide a wide range of services to promote wellness, longevity, and disease prevention for the residents of Abu Dhabi. The department has also announced the licensing of IHLAD as the first specialised Healthy Longevity Medicine Centre in the world. Organised by the Abu Dhabi Public Health Centre (ADPHC) in collaboration with the International Union for Health Promotion and Education (IUHPE), the 25th IUHPE World Conference on Health Promotion brings together more than 2,000 global experts, policymakers, and practitioners to explore practical solutions to today's most pressing public health challenges. With a focus on prevention, innovation, and cross-sector collaboration, the event reflects Abu Dhabi's growing role as a hub for sustainable, inclusive, and forward-looking public health systems. Source: Aletihad - Abu Dhabi
Zawya
14-05-2025
- Health
- Zawya
Abu Dhabi Public Health Centre and Novartis Middle East sign MoU
Abu Dhabi: The Abu Dhabi Public Health Centre (ADPHC) has signed a Memorandum of Understanding (MoU) with Novartis Middle East FZE (Novartis), an Innovative Medicine's company, to raise awareness, advance prevention, and improve disease management practices, particularly for cardiovascular diseases, diabetes, and chronic kidney disease in Abu Dhabi Emirate. The MoU was signed by H.E. Rashed Obaid Alsuwaidi - Director General, representing ADPHC, and Mohamed Ezz Eldin, Head of GCC, representing Novartis, on May 13, during the 25th IUHPE World Conference on Health Promotion, which is taking place from 13 to 16 May, 2025, at the Abu Dhabi National Exhibition Centre (ADNEC). H.E. Dr. Rashed Obaid Alsuwaidi - Director General of ADPHC said: 'This MoU is a vital step in our journey to strengthen public health systems and reduce the impact of non-communicable diseases in Abu Dhabi. We aim to deliver long-term, sustainable health outcomes for our population through strategic collaborations.' Mohamed Ezz Eldin, Head of GCC at Novartis said: 'We are proud to partner with the Abu Dhabi Public Health Centre in a mission that aligns with our commitment to advancing patient care. Together, we can reimagine medicine to ensure patients get the best care, and we believe we can make a measurable impact on people's lives through awareness, early detection, and proactive disease management.' The strategic collaboration between the two entities highlights a mutual commitment to leveraging public health approaches with private sector innovation to promote healthier lifestyles and enhance community well-being in Abu Dhabi. Under the two-year agreement, ADPHC and Novartis will collaborate to create and execute awareness campaigns via digital and traditional channels, raising the public awareness about risk factors, early symptoms, and the significance of regular screenings for non-communicable diseases. The collaboration is built around three strategic pillars: Disease Awareness: Co-developing impactful campaigns to raise public awareness and educate communities about non-communicable diseases such as cardiovascular conditions, diabetes, and chronic kidney disease. These initiatives will leverage online and offline channels to encourage proactive health behaviours like routine testing. Disease Prevention: Designing and implementing effective initiatives focused on the primary prevention of adult cardiovascular diseases, diabetes, and chronic kidney disease. Activities include targeted screening efforts to identify at-risk individuals early. Best Practice Sharing in Disease Management: Collaborating to identify, share, and implement best practices across the patient journey. This includes early screening protocols, preventive strategies, and disease management models, drawing on global expertise amd best practices to enhance patient outcomes and improve healthcare system performance. The MoU also establishes a dedicated taskforce, with each party appointing a lead to coordinate efforts. The task force will meet regularly to align on project plans, assess feasibility, define key deliverables, and evaluate outcomes through jointly agreed key performance indicators (KPIs). The KPIs will be reviewed biannually to ensure alignment with strategic goals and to adapt to emerging public health needs. About ADPHC: The law No. (14) of 2019 for establishing Abu Dhabi Public Health Center was issued by the late His Highness Sheikh Khalifa bin Zayed Al Nahyan, (may his soul rest in peace) on April 23, 2019. The law aims to issue a public health system. The system aims to preserve the health of the Emirate's population and ensure the safety of its workers by promoting concepts of public health and preventive health. It is concerned with collecting evidence and data on accidents and serious occupational injuries in coordination with the concerned authorities, to determine their causes and reduce their risks, registering all technical service providers and specialists licensed by the department in the fields of public health and preventive health, and ensuring review and approval of the systems of the entities operating in the emirate, in accordance with the requirements of the system. Novartis Middle East FZE Phone: +971 4 8185448 Email:
Zawya
14-05-2025
- Health
- Zawya
Abu Dhabi, Novartis Middle East sign deal to enhance public health awareness in emirate
ABU DHABI: The Abu Dhabi Public Health Centre (ADPHC) has signed a Memorandum of Understanding (MoU) with Novartis Middle East FZE (Novartis), an Innovative Medicine's company, to raise awareness, advance prevention, and improve disease management practices, particularly for cardiovascular diseases, diabetes, and chronic kidney disease in Abu Dhabi Emirate. The MoU was signed by Rashed Obaid Alsuwaidi - Director General, representing ADPHC, and Mohamed Ezz Eldin, Head of GCC, representing Novartis, on May 13, during the 25th IUHPE World Conference on Health Promotion, which is taking place from 13 to 16 May, 2025, at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Rashed Obaid Alsuwaidi - Director General of ADPHC said: 'This MoU is a vital step in our journey to strengthen public health systems and reduce the impact of non-communicable diseases in Abu Dhabi. We aim to deliver long-term, sustainable health outcomes for our population through strategic collaborations.' Mohamed Ezz Eldin, Head of GCC at Novartis said: 'We are proud to partner with the Abu Dhabi Public Health Centre in a mission that aligns with our commitment to advancing patient care. Together, we can reimagine medicine to ensure patients get the best care, and we believe we can make a measurable impact on people's lives through awareness, early detection, and proactive disease management.' The strategic collaboration between the two entities highlights a mutual commitment to leveraging public health approaches with private sector innovation to promote healthier lifestyles and enhance community well-being in Abu Dhabi. Under the two-year agreement, ADPHC and Novartis will collaborate to create and execute awareness campaigns via digital and traditional channels, raising the public awareness about risk factors, early symptoms, and the significance of regular screenings for non-communicable diseases. The collaboration is built around three strategic pillars: -Disease Awareness: Co-developing impactful campaigns to raise public awareness and educate communities about non-communicable diseases such as cardiovascular conditions, diabetes, and chronic kidney disease. These initiatives will leverage online and offline channels to encourage proactive health behaviours like routine testing. -Disease Prevention: Designing and implementing effective initiatives focused on the primary prevention of adult cardiovascular diseases, diabetes, and chronic kidney disease. Activities include targeted screening efforts to identify at-risk individuals early. -Best Practice Sharing in Disease Management: Collaborating to identify, share, and implement best practices across the patient journey. This includes early screening protocols, preventive strategies, and disease management models, drawing on global expertise amd best practices to enhance patient outcomes and improve healthcare system performance. The MoU also establishes a dedicated taskforce, with each party appointing a lead to coordinate efforts. The task force will meet regularly to align on project plans, assess feasibility, define key deliverables, and evaluate outcomes through jointly agreed key performance indicators (KPIs). The KPIs will be reviewed biannually to ensure alignment with strategic goals and to adapt to emerging public health needs.
Al Etihad
13-05-2025
- Health
- Al Etihad
ADPHC, Novartis Middle East sign MoU to enhance public health awareness, disease prevention in Abu Dhabi
13 May 2025 23:59 ABU DHABI (WAM)The Abu Dhabi Public Health Centre (ADPHC) has signed a Memorandum of Understanding (MoU) with Novartis Middle East FZE (Novartis), an Innovative Medicine company, to raise awareness, advance prevention, and improve disease management practices, particularly for cardiovascular diseases, diabetes, and chronic kidney disease in Abu Dhabi emirate. The MoU was signed by Rashed Obaid Alsuwaidi - Director General, representing ADPHC, and Mohamed Ezz Eldin, Head of GCC, representing Novartis, on May 13, during the 25th IUHPE World Conference on Health Promotion, which is taking place from May 13 to 16 , 2025, at the Abu Dhabi National Exhibition Centre (ADNEC). Dr. Rashed Obaid Alsuwaidi - Director General of ADPHC said, "This MoU is a vital step in our journey to strengthen public health systems and reduce the impact of non-communicable diseases in Abu Dhabi. We aim to deliver long-term, sustainable health outcomes for our population through strategic collaborations."Mohamed Ezz Eldin, Head of GCC at Novartis said, "We are proud to partner with the Abu Dhabi Public Health Centre in a mission that aligns with our commitment to advancing patient care. Together, we can reimagine medicine to ensure patients get the best care, and we believe we can make a measurable impact on people's lives through awareness, early detection, and proactive disease management."The strategic collaboration between the two entities highlights a mutual commitment to leveraging public health approaches with private sector innovation to promote healthier lifestyles and enhance community well-being in Abu the two-year agreement, ADPHC and Novartis will collaborate to create and execute awareness campaigns via digital and traditional channels, raising the public awareness about risk factors, early symptoms, and the significance of regular screenings for non-communicable collaboration is built around three strategic pillars:-Disease Awareness: Co-developing impactful campaigns to raise public awareness and educate communities about non-communicable diseases such as cardiovascular conditions, diabetes, and chronic kidney disease. These initiatives will leverage online and offline channels to encourage proactive health behaviours like routine testing.-Disease Prevention: Designing and implementing effective initiatives focused on the primary prevention of adult cardiovascular diseases, diabetes, and chronic kidney disease. Activities include targeted screening efforts to identify at-risk individuals early.-Best Practice Sharing in Disease Management: Collaborating to identify, share, and implement best practices across the patient journey. This includes early screening protocols, preventive strategies, and disease management models, drawing on global expertise amd best practices to enhance patient outcomes and improve healthcare system performance. The MoU also establishes a dedicated taskforce, with each party appointing a lead to coordinate efforts. The task force will meet regularly to align on project plans, assess feasibility, define key deliverables, and evaluate outcomes through jointly agreed key performance indicators (KPIs). The KPIs will be reviewed biannually to ensure alignment with strategic goals and to adapt to emerging public health needs.
The National
11-04-2025
- Health
- The National
Sustaining and advancing Abu Dhabi's healthcare system resilience
While health systems around the world are racing to keep up with rising health challenges, Abu Dhabi is already building what's next. The emirate is demonstrating what a future-ready healthcare ecosystem looks like, integrated, intelligent and resilient by design. Around the world, healthcare systems are under increasing strain, from surging demand and ageing populations to rising chronic diseases, climate change and unforeseen emergencies. The question facing global leaders today is no longer whether our systems will be tested, but how fast they can transform to be prepared to deliver care consistently, efficiently and equitably, regardless of disruption. Abu Dhabi is answering that question with a clear, future-facing strategy. As it hosts Abu Dhabi Global Health Week, the emirate is not simply showcasing ambition, it is demonstrating how health systems can be reimagined to be resilient and responsive, ready for any challenge while ensuring continuity of care. Healthcare resilience requires more than crisis response, it demands proactive systems that protect vulnerable populations, maintain essential services and continue operating under stress. Abu Dhabi has moved decisively to build those systems, starting with the Unified Medical Operations Command Centre, a centralised platform that connects hospital care, ambulance services, outbreak response and medical logistics in one place, a first of its kind model, launched by the Department of Health – Abu Dhabi in collaboration with public and private sector partners. This integrated hub brings together regulation, pre-hospital services, hospital admissions and strategic medical stockpile management under a single operational umbrella. More than just co-ordination, it represents a fundamental shift in emergency health infrastructure to ensure operations are efficient, predictive and scalable. In a recent operational trial, the system reduced emergency response times by up to 28 per cent, allowing patients to access critical care faster, a real-world example of resilience in action. Powered by an AI-enabled platform, the centre can identify potential outbreaks early and mobilise resources in real time, providing a foundation of readiness embedded within daily operations. In 2024, the system successfully flagged early indicators of a potential measles outbreak, prompting a swift vaccination campaign that helped prevent its spread and safeguard the health of the wider community 'Our aim is not only to respond faster, but to be ready at all times,' said Dr Rashed Obaid Alsuwaidi, director general of Abu Dhabi Public Health Centre. 'This means unifying intelligence, logistics and care pathways into one system that adapts as needs evolve.' Abu Dhabi's approach to resilience isn't theoretical, it's operational. At the heart of its emergency medical ecosystem is H100, an intelligent command and control system that acts as the digital backbone of crisis response. In a medical emergency, H100 connects frontline teams with real-time data on hospital capacity, patient severity and facility specialisations. Commanders can coordinate directly with ambulance crews to determine the most appropriate facility based on current load and care capability. Doctors in receiving hospitals can communicate directly with ambulance teams while patients are en route, ensuring seamless, informed care delivery from the field to the operating room. Since its introduction, H100 has helped reduce unnecessary hospital transfers and improved triage efficiency by 35%, translating to faster care and better outcomes for patients across Abu Dhabi. Beyond individual emergencies, H100 is linked to a Geographic Information System (GIS) that enables rapid triage and response in mass casualty situations. This technology not only directs patients to the right facility, but it can also identify when and where to deploy field hospitals, preventing bottlenecks and preserving system stability. In essence, Abu Dhabi is building a healthcare system where technology and medical expertise converge in real time, delivering the right care, in the right place and at the right moment. Yet true resilience goes beyond emergency response. It requires continuous innovation and system-wide evolution. Abu Dhabi's healthcare strategy incorporates innovation and foresight at every level, which integrates digital technologies across care settings, to its global research partnerships that advance preventative health solutions. A key initiative is the Ma'an Fund, supported by the Department of Health – Abu Dhabi, the Bill and Melinda Gates Foundation, M42 and Mubadala. The fund empowers local stakeholders to conduct impactful, real-world research on topics ranging from chronic disease management to new diagnostic technologies. To date, it has funded 11 projects that are shaping the future of inclusive, sustainable healthcare delivery. Strategic collaborations further amplify these efforts. Abu Dhabi's agreement with GSK to establish a regional vaccine distribution hub reflects not just logistical strength, but a commitment to prevention and equitable access across the region. What differentiates Abu Dhabi is its ability to integrate forward-looking policy with operational agility, linking public and private sectors to deliver real-time impact and long-term value. This also strengthens its role as a health leader in the region. This is resilience in practice, investing upstream to mitigate downstream risk. Abu Dhabi recognises that resilience cannot be achieved in isolation. Through partnerships with the International Federation of Emergency Medicine, the emirate contributes to shaping global best practices and strengthening emergency medicine capacity worldwide. These efforts are complemented by knowledge exchange and clinical excellence partnerships with institutions such as Cleveland Clinic Abu Dhabi and world-leading universities. By building world-class expertise and aligning with global standards, Abu Dhabi is ensuring its health system is robust and continuously improving. As the host of Abu Dhabi Global Health Week (ADGHW), the emirate is inviting global leaders to co-design the health systems of the future. This platform serves as a space not just for discussion, but for action, driving forward strategies that are adaptive, inclusive and scalable. Abu Dhabi Global Health Week is not only a forum, it is a launchpad for health diplomacy, global collaboration, and innovation-driven change that serves national goals and international needs. 'Building future-ready systems requires more than infrastructure. It demands vision, cooperation and shared responsibility,' said Dr Alsuwaidi. 'In a region where co-operation is key and healthcare demand is rising, Abu Dhabi is extending an open invitation: join us in building a resilient health future, together,' he concludes. More information about Abu Dhabi Global Health Week is at This page was produced by The National in partnership with Abu Dhabi Global Health Week 2025
